Eosinophilic Esophagitis - Healthcare Professionals

A Randomized double-blindplacebo-controlled trial ofFluticasone Proprianate for EoE• 31 patients: 20 treated with fluticasone880mcg/day and 11 placebo treated controlsfor 3 months• Primary endpoint: histologic with eosinophilcount < 1/hpf.• Results: 50% in treatment and 9% in placebogroup demonstrated histologic remission.• Younger age, shorter height, lighter weightand non-allergic pts were positive predictorsof response.